Mild COVID-19 patients exhibited higher levels of IgM to glycerophosphoinositol (IgMPI), glycerophosphoserine (IgMPS), and sulfatides (IgMSUL) than severe COVID-19 patients and the control group (Figures 1A–D). Here, CD40LG is linked to COVID-19.